LAS VEGAS, Sep 24, 2007 (BUSINESS WIRE) -- Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRPR), a leading developer and marketer of powdered nutritional ingredients, announces it has again received renewal of its Kosher certification for the company's O2P(TM) family of oil powders.
Kosher certification guarantees that both the ingredients and manufacturing equipment used to produce O2P(TM) Powders meet the stringent requirements of "Kashrus" or Jewish dietary laws.
According to NPRI president and CEO, Godfrey Yew, "Maintaining our Kosher certification is important for the present and future growth of our company. Kosher certification is further proof of our commitment to providing the highest quality, purity and consistency in our O2P powdered oils to the food and nutraceutical industries."
Certification was provided by OK Kosher Certification, whose "OK" is among the world's most respected kosher symbols, establishing the standards for kosher in the United States, Europe and the Orient.
Copies of the certifications are on file and available upon request.
Nutri Pharmaceuticals Research Inc. ( www.o2pus.com) provides a wide range of powdered oils for functional food, food supplement; pharmaceutical; cosmetic; pet food and animal feed applications.
The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P(TM) Powderization process. At the heart of its oil powders is the O2P(TM) Oil-to-Powder technology. This patent-pending process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P(TM) does not rely on traditional techniques that utilize extremes in heat or cold, micro-encapsulation or nanotechnology. This facilitates food marketing and supplement producers' ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues.
The company currently offers more than 50 shelf-stable powders. The company can also apply O2P(TM) technology to a third-party's oil, paste or gel through an arrangement called tolling. Based in Las Vegas, the company has representative sales offices near Chicago, Amsterdam, Guatemala City and Bangkok.
Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "Pinksheets" under the symbol NRPR.PK.
All statements contained in this Press Release, other than statements of historical facts, that address future activities, events or developments are forward-looking statements, including, but not limited to, statements containing the words "believe," "anticipate," "expect" and words of similar import. These statements are based on certain assumptions and analyses made by us in light of our experience and our assessment of historical trends, current conditions and expected future developments as well as other factors we believe are appropriate under the circumstances. However, whether actual results will conform to the expectations and predictions of management is subject to a number of risks and uncertainties that may cause actual results to differ materially.
Such risks include, among others, the following: international, national and local general economic and market conditions: our ability to sustain, manage or forecast our growth; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other factors referenced in this and previous disclosures.
Consequently, all of the forward-looking statements made in this Press Release are qualified by these cautionary statements and there can be no assurance that the actual results anticipated by management will be realized or, even if substantially realized, that they will have the expected results or consequences to or effects on our business operations.